The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic

Esophageal adenocarcinoma (EAC) is a poor prognosis cancer type with rapidly rising incidence. Our understanding of genetic events that drive EAC development is limited, and there are few molecular biomarkers for prognostication or therapeutics. Using a cohort of 551 genomically characterized EACs w...

Descripción completa

Detalles Bibliográficos
Autores principales: Frankell, Alexander M, Jammula, SriGanesh, Li, Xiaodun, Contino, Gianmarco, Killcoyne, Sarah, Abbas, Sujath, Perner, Juliane, Bower, Lawrence, Devonshire, Ginny, Ococks, Emma, Grehan, Nicola, Mok, James, O’Donovan, Maria, MacRae, Shona, Eldridge, Matthew D., Tavaré, Simon, Fitzgerald, Rebecca C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420087/
https://www.ncbi.nlm.nih.gov/pubmed/30718927
http://dx.doi.org/10.1038/s41588-018-0331-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420087/
https://www.ncbi.nlm.nih.gov/pubmed/30718927
http://dx.doi.org/10.1038/s41588-018-0331-5

Ejemplares similares